How 908 Devices is utilizing automation to improve cell and

How 908 Devices is utilizing automation to improve cell and gene therapy

We caught up with Kevin Knopp, CEO and co-founder of 908 Devices, to discuss the main obstacles in cell and gene therapy manufacturing and how the company's recent partnership with Terumo Blood and Cell Technologies is tackling these challenges.

Related Keywords

Kevin Knopp , , Terumo Blood , Cell Technologies , Quantum Flex , Bio Developments , Markets Amp Regulations , Cell Amp Gene Therapies , Utomation , Cell And Gene Therapy , Ell And Gene Technologies , Terumo ,

© 2025 Vimarsana